TNDM.NASDAQTandem Diabetes Care INC

Form 4: Tandem Diabetes Care Executive James Leal Reports Stock Transactions

Sentiment:

SEC Form 4 Filing

📋All filings for Tandem Diabetes Care INC
🔒Login to Follow

James Leal, Chief Manufacturing Officer at Tandem Diabetes Care, reports the vesting of restricted stock units and subsequent tax withholding.

Summary

  • On February 27, 2024, James Leal, Chief Manufacturing Officer of Tandem Diabetes Care Inc., reported transactions involving the company's stock.
  • Leal acquired 309 shares of common stock through the vesting of restricted stock units (RSUs) at a price of $0.
  • Simultaneously, 125 shares were withheld by Tandem Diabetes Care to satisfy tax obligations related to the RSU vesting at a price of $27.34.
  • Following these transactions, Leal directly owns 10,816 shares of Tandem Diabetes Care common stock.

Sentiment

Score: 5

Explanation: The document reflects standard executive compensation practices and doesn't indicate any unusual or concerning activity. It's a neutral disclosure.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their stock transactions. It is a normal part of executive compensation and equity management.

Stakeholder Impact

  • The transaction has a minor impact on shareholders as it involves the vesting of previously awarded equity.

Key Dates

DateDescription
May 27, 2020Date of RSU award under the 2013 Stock Incentive Plan.
May 27, 2021First vesting date (25%) of the awarded RSUs.
February 27, 2024Date of stock transactions: RSU vesting and tax withholding.
February 29, 2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.